Generics As a result of generic erosion for key agents such as Pfizer's Effexor XR (venlafaxine), Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar (duloxetine) and Forest Laboratories/Lundbeck's Lexapro/Cipralex/Seroplex (escitalopram), the unipolar depression drug market will decrease in size by nearly 10% over the next decade in the USA, France, Germany, Italy, Spain, the UK and Japan, according to a new report from Decision Resources. 12 August 2010